59 related articles for article (PubMed ID: 35900852)
1. The multi-faceted role of retinoid X receptor in bone remodeling.
Menéndez-Gutiérrez MP; Ricote M
Cell Mol Life Sci; 2017 Jun; 74(12):2135-2149. PubMed ID: 28105491
[TBL] [Abstract][Full Text] [Related]
2. Agonist-controlled competition of RAR and VDR nuclear receptors for heterodimerization with RXR is manifested in their DNA binding.
Rehó B; Fadel L; Brazda P; Benziane A; Hegedüs É; Sen P; Gadella TWJ; Tóth K; Nagy L; Vámosi G
J Biol Chem; 2023 Feb; 299(2):102896. PubMed ID: 36639026
[TBL] [Abstract][Full Text] [Related]
3. Rational Design of a New RXR Agonist Scaffold Enabling Single-Subtype Preference for RXRα, RXRβ, and RXRγ.
Adouvi G; Isigkeit L; López-García Ú; Chaikuad A; Marschner JA; Schubert-Zsilavecz M; Merk D
J Med Chem; 2023 Jan; 66(1):333-344. PubMed ID: 36533416
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR Isoforms.
Chaikuad A; Pollinger J; Rühl M; Ni X; Kilu W; Heering J; Merk D
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187070
[TBL] [Abstract][Full Text] [Related]
5. Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.
Atigadda VR; Kashyap MP; Yang Z; Chattopadhyay D; Melo N; Sinha R; Belyaeva OV; Chou CF; Chang PL; Kedishvili NY; Grubbs CJ; Renfrow MB; Muccio DD; Elmets CA; Athar M
J Med Chem; 2022 Nov; 65(21):14409-14423. PubMed ID: 36318154
[TBL] [Abstract][Full Text] [Related]
6. Direct evaluation of polarity of the ligand binding pocket in retinoid X receptor using a fluorescent solvatochromic agonist.
Miura K; Fujihara M; Watanabe M; Takamura Y; Kawasaki M; Nakano S; Kakuta H
Bioorg Med Chem Lett; 2023 Nov; 96():129536. PubMed ID: 37913851
[TBL] [Abstract][Full Text] [Related]
7. Nuclear receptors in bone physiology and diseases.
Imai Y; Youn MY; Inoue K; Takada I; Kouzmenko A; Kato S
Physiol Rev; 2013 Apr; 93(2):481-523. PubMed ID: 23589826
[TBL] [Abstract][Full Text] [Related]
8. Triphenyltin isoselenocyanate: a novel nuclear retinoid X receptor ligand with antiproliferative and cytotoxic properties in cell lines derived from human breast cancer.
Macejova D; Kollar J; Bobal P; Otevrel J; Schuster D; Brtko J
Mol Cell Biochem; 2024 Jan; ():. PubMed ID: 38227157
[TBL] [Abstract][Full Text] [Related]
9. Retinoic Acid and Retinoid X Receptors.
Schubert M; Germain P
Cells; 2023 Mar; 12(6):. PubMed ID: 36980205
[TBL] [Abstract][Full Text] [Related]
10. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
Dominguez M; Alvarez S; de Lera AR
Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
[TBL] [Abstract][Full Text] [Related]
12. Design and in vitro characterization of RXR variants as tools to investigate the biological role of endogenous rexinoids.
le Maire A; Rey M; Vivat V; Guée L; Blanc P; Malosse C; Chamot-Rooke J; Germain P; Bourguet W
J Mol Endocrinol; 2022 Oct; 69(3):377-390. PubMed ID: 35900852
[TBL] [Abstract][Full Text] [Related]
13. Alternative retinoid X receptor (RXR) ligands.
Krężel W; Rühl R; de Lera AR
Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
[TBL] [Abstract][Full Text] [Related]
14. Ligand Design for Modulation of RXR Functions.
Martínez C; Souto JA; de Lera AR
Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
[TBL] [Abstract][Full Text] [Related]
15. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
